MedPath

Gyongyi Szabo

🇦🇹Austria
Ownership
-
Employees
-
Market Cap
-
Website

A Pilot, Dose Escalating Study on VLX103 in Moderate Alcoholic Steatohepatitis

Phase 1
Withdrawn
Conditions
Hepatic Steatosis
Interventions
First Posted Date
2017-06-28
Last Posted Date
2018-05-30
Lead Sponsor
Gyongyi Szabo
Registration Number
NCT03201159
Locations
🇺🇸

UMass Medical School, Worcester, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath